A new study evaluating a cell-based immune therapy to treat an aggressive type of leukemia — the largest study of its kind to date — reports that 88 percent of patients responded to the treatment. read more

See more here:
New Trial Advances Cell-Based Immune Therapy for Certain Leukemias

Scroll to Top